Published in Calcif Tissue Int on November 01, 1999
2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ (2002) 9.89
Biochemical markers of bone turnover part II: clinical applications in the management of osteoporosis. Clin Biochem Rev (2006) 1.01
Alendronate treatment results in similar levels of trabecular bone remodeling in the femoral neck and vertebra. Osteoporos Int (2008) 0.84
Zoledronate induces bisphosphonate-related osteonecrosis of the jaw in osteopenic sheep. Clin Oral Investig (2015) 0.78
Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover. Osteoporos Int (2009) 0.77
Peri-implant and systemic effects of high-/low-affinity bisphosphonate-hydroxyapatite composite coatings in a rabbit model with peri-implant high bone turnover. BMC Musculoskelet Disord (2012) 0.76
Baseline mineralizing surface determines the magnitude of the bisphosphonate effect on cortical bone mineralization in postmenopausal osteoporotic patients. J Musculoskelet Neuronal Interact (2017) 0.75
Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int (1999) 2.70
Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study. J Hepatol (2007) 2.12
Comparison of scoring systems and outcome of patients admitted to a liver intensive care unit of a tertiary referral centre with severe variceal bleeding. Aliment Pharmacol Ther (2014) 1.98
Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study. J Bone Miner Res (1995) 1.79
Lipoprotein(a) and lipoprotein profile in healthy centenarians: a reappraisal of vascular risk factors. FASEB J (1998) 1.77
Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial. JAMA (2001) 1.72
Health-related quality of life and radiographic vertebral fracture. Osteoporos Int (2003) 1.70
Risk factors for hip fracture in men from southern Europe: the MEDOS study. Mediterranean Osteoporosis Study. Osteoporos Int (1999) 1.59
Incidence of limb fracture across Europe: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (2002) 1.56
Prevalence of coeliac disease in primary biliary cirrhosis and of antimitochondrial antibodies in adult coeliac disease patients in Italy. Dig Liver Dis (2002) 1.50
The variable incidence of hip fracture in southern Europe: the MEDOS Study. Osteoporos Int (1994) 1.46
Cold snare excision of small colorectal polyps. Gastrointest Endosc (1992) 1.46
Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (2003) 1.45
Urinary calcium excretion in the monitoring of bone metastases from prostatic carcinoma. Cancer (2001) 1.43
Sjögren's syndrome and pure red cell aplasia. Clin Exp Rheumatol (1996) 1.37
Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience. Bone (2003) 1.34
Hematuria and rectal bleeding in the child with Klippel and Trenaunay syndrome. Ann Surg (1976) 1.31
Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients. J Clin Invest (1986) 1.28
Conformational and molecular basis for induction of apoptosis by a p53 C-terminal peptide in human cancer cells. J Biol Chem (1999) 1.27
Squamous papilloma of the esophagus: long-term follow up. J Gastroenterol Hepatol (2001) 1.24
Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment. J Clin Invest (1988) 1.22
Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trials. Arch Intern Med (2000) 1.17
Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study. Calcif Tissue Int (1986) 1.10
Cardiovascular effects of calcitonin gene-related peptides I and II in man. Circ Res (1987) 1.08
Exemestane after tamoxifen as adjuvant hormonal therapy in postmenopausal women with breast cancer: effects on body composition and lipids. Br J Cancer (2006) 1.08
Alendronate treatment in men with primary osteoporosis: a three-year longitudinal study. Calcif Tissue Int (2003) 1.07
Genomic alterations of the p19ARF encoding exons in T-cell acute lymphoblastic leukemia. Blood (1998) 1.07
Effect of simvastatin treatment on bone mineral density and bone turnover in hypercholesterolemic postmenopausal women: a 1-year longitudinal study. Bone (2003) 1.07
Effects of one-year treatment with estrogens on bone mass, intestinal calcium absorption, and 25-hydroxyvitamin D-1 alpha-hydroxylase reserve in postmenopausal osteoporosis. Calcif Tissue Int (1988) 1.03
Intratumor heterogeneity of K-ras2 mutations in colorectal adenocarcinomas: association with degree of DNA aneuploidy. Am J Pathol (1996) 1.02
Glucocorticoid-induced osteoporosis. Clin Rheum Dis (1986) 1.01
Dietary L-lysine and calcium metabolism in humans. Nutrition (1993) 1.00
Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture. BMJ (1992) 1.00
Hyperuricemia and gout in thyroid endocrine disorders. Clin Exp Rheumatol (2002) 1.00
Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans. Calcif Tissue Int (1984) 1.00
Changes in bone turnover and in bone mass in women with breast cancer switched from tamoxifen to exemestane. Bone (2006) 0.99
Validation of a food frequency questionnaire for nutritional calcium intake assessment in Italian women. Eur J Clin Nutr (2002) 0.98
Paget's disease of bone: diagnosis and management. BMJ (1996) 0.98
Recommendations for the registration of new chemical entities used in the prevention and treatment of osteoporosis. Calcif Tissue Int (1995) 0.97
Olive-oil-enriched diet: effect on serum lipoprotein levels and biliary cholesterol saturation. Am J Clin Nutr (1988) 0.97
Most Helicobacter pylori-infected patients have specific antibodies, and some also have H. pylori antigens and genomic material in bile: is it a risk factor for gallstone formation? Dig Dis Sci (1998) 0.97
Bone ultrasonography at phalanxes in patients with Rett syndrome: a 3-year longitudinal study. Bone (2007) 0.96
Dual X-ray absorptiometry and bone ultrasonography in patients with Rett syndrome. Calcif Tissue Int (2001) 0.96
Changes in serum HDL and LDL cholesterol in patients with Paget's bone disease treated with pamidronate. Bone (2003) 0.96
Clinical utility of bone mass measurements in adults: consensus of an international panel. The Society for Clinical Densitometry. Semin Arthritis Rheum (1996) 0.95
Cardiovascular action of calcitonin gene-related peptide in humans. Calcif Tissue Int (1985) 0.95
Notch1 signaling regulates chondrogenic lineage determination through Sox9 activation. Cell Death Differ (2011) 0.94
The infection by Helicobacter pylori strains expressing CagA is highly prevalent in women with autoimmune thyroid disorders. J Physiol Pharmacol (1999) 0.93
Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: evidence of multiple gene contribution to bone mineral density. J Clin Endocrinol Metab (1998) 0.93
The use of platelet gel in postero-lateral fusion: preliminary results in a series of 14 cases. Eur Spine J (2011) 0.93
Effects of prednisone and deflazacort on vertebral bone mass. Calcif Tissue Int (1985) 0.92
Tissue transglutaminase is a caspase substrate during apoptosis. Cleavage causes loss of transamidating function and is a biochemical marker of caspase 3 activation. Cell Death Differ (1999) 0.92
Effects of pravastatin treatment on vitamin D metabolites. Clin Ther (1995) 0.91
Genetic markers of osteoarticular disorders: facts and hopes. Arthritis Res (2001) 0.91
Serum osteocalcin concentration in patients with prostatic cancer. Am J Clin Oncol (1988) 0.90
Trends in the incidence of hip fracture in Siena, Italy, from 1980 to 1991. Bone (1993) 0.90
Mild brachydactyly type A1 maps to chromosome 2q35-q36 and is caused by a novel IHH mutation in a three generation family. J Med Genet (2003) 0.89
Polymorphisms of the calcitonin receptor gene are associated with bone mineral density in postmenopausal Italian women. Biochem Biophys Res Commun (1998) 0.89
Definition of a population-specific DXA reference standard in Italian women: the Densitometric Italian Normative Study (DINS). Osteoporos Int (2003) 0.89
Metabolic and clinical effects of ipriflavone in established post-menopausal osteoporosis. Drugs Exp Clin Res (1989) 0.89
Hereditary hyperlipidemia in the rabbit due to overproduction of lipoproteins. I. Biochemical studies. Arteriosclerosis (1987) 0.88
FokI polymorphism of the vitamin D receptor gene correlates with parameters of bone mass and turnover in a female population of the Italian island of Lampedusa. Calcif Tissue Int (2006) 0.88
Allelic variants of human calcitonin receptor: distribution and association with bone mass in postmenopausal Italian women. Biochem Biophys Res Commun (1998) 0.88
Activity of omeprazole on Helicobacter pylori and relation to toxicity of strains. J Clin Pathol (1994) 0.88
Vitamin D receptor genotypes and intestinal calcium absorption in postmenopausal women. Calcif Tissue Int (1997) 0.88
Falls explain between-center differences in the incidence of limb fracture across Europe. Bone (2002) 0.88
The usefulness of bone turnover in predicting the response to transdermal estrogen therapy in postmenopausal osteoporosis. J Bone Miner Res (1997) 0.87
Helicobacter pylori infection and infertility. Eur J Gastroenterol Hepatol (2002) 0.87
Side-effects of synthetic salmon and human calcitonin. Lancet (1983) 0.86
p53 mutations and DNA ploidy in colorectal adenocarcinomas. Anal Cell Pathol (1998) 0.86
Evaluation of minimal residual disease using reverse-transcription polymerase chain reaction in t(8;21) acute myeloid leukemia: a multicenter study of 51 patients. J Clin Oncol (2000) 0.86
Urinary excretion of cyclic adenosine 3',5'-monophosphate and cyclic guanosine 3',5'-monophosphate in malignancy. J Clin Pathol (1978) 0.86
Food allergy and Helicobacter pylori infection. Ital J Gastroenterol Hepatol (1999) 0.86
[Guidelines for the diagnosis, prevention and treatment of osteoporosis]. Reumatismo (2010) 0.85
Letter: Diphosphonate therapy in deafness associated with Paget's disease. Br Med J (1975) 0.85
Comparison of the low energy conformations of an oncogenic and a non-oncogenic p21 protein, neither of which binds GTP or GDP. J Protein Chem (1994) 0.85
Proteus syndrome. Ultrastructural study of linear verrucous and depigmented nevi. J Am Acad Dermatol (1991) 0.85
Prevention of corticosteroid-induced osteoporosis with alendronate in sarcoid patients. Calcif Tissue Int (1997) 0.85
Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of bone. Arthritis Rheum (1995) 0.85
Modified plasma-derived lipoproteins in human atherosclerotic plaques. Atherosclerosis (1988) 0.85